Inserm, U769, Univ. Paris Sud, IFR141, Labex Lermit, Châtenay-Malabry, France.
J Mol Cell Cardiol. 2012 Nov;53(5):617-25. doi: 10.1016/j.yjmcc.2012.08.004. Epub 2012 Aug 19.
Cardiac actions of Epac (exchange protein directly activated by cAMP) are not completely elucidated. Epac induces cardiomyocytes hypertrophy, Ca(2+)/calmodulin protein kinase II (CaMKII) and excitation-transcription coupling in rat cardiac myocytes. Here we aimed to elucidate the pathway cascade involved in Epac sustained actions, as during the initiation of hypertrophy development, where β-adrenergic signaling is chronically stimulated. Rats were treated with the Epac selective activator 8-pCPT during 4 weeks and Ca(2+) signaling was analyzed in isolated cardiac myocytes by confocal microscopy. We observed a positive inotropic effect manifested by increased Ca(2+) transient amplitudes. In order to further analyze these actions, we incubated adult cardiomyocytes in the presence of 8-pCPT. The effects were similar to those obtained in-vivo and are blunted by Epac1 knock down. Interestingly, the increase in [Ca(2+)] transients was abolished by protein synthesis blockade or when the downstream effectors of calmodulin (CaMKII or calcineurin) were inhibited, pointing to calmodulin (CaM) as an important downstream protein in Epac sustained actions. In fact, CaM expression was enhanced by 8-pCPT treatment in isolated cells, as found by Western blots. Moreover, the 8-pCPT-induced, PKA-independent, positive inotropic effect was favored by enhanced extracellular Ca(2+) influx via L-type Ca(2+) channels. However, 8-pCPT also induced aberrant Ca(2+) release as Ca(2+) waves and extra Ca(2+) transients, suggesting proarrhythmic effect. These results provide new insights regarding Epac cardiac actions, suggesting an important role in the initial compensation of the heart to pathological stimuli during the initiation of cardiac hypertrophy, favoring contraction but also arrhythmia risk.
环腺苷酸(cAMP)直接激活交换蛋白(Epac)的心脏作用尚未完全阐明。Epac 可诱导心肌细胞肥大、钙/钙调蛋白蛋白激酶 II(CaMKII)和兴奋-转录偶联,在大鼠心肌细胞中。在这里,我们旨在阐明 Epac 持续作用所涉及的途径级联,因为在肥大发展的起始阶段,β-肾上腺素能信号被慢性刺激。大鼠用 Epac 选择性激活剂 8-pCPT 处理 4 周,并用共聚焦显微镜分析分离的心肌细胞中的钙信号。我们观察到正性变力作用,表现为[Ca 2+](i)瞬变幅度增加。为了进一步分析这些作用,我们在存在 8-pCPT 的情况下孵育成年心肌细胞。这些作用与体内获得的作用相似,并被 Epac1 敲低所减弱。有趣的是,[Ca 2+]瞬变的增加被蛋白质合成阻断或当钙调蛋白(CaMKII 或钙调神经磷酸酶)的下游效应物被抑制时被消除,表明钙调蛋白(CaM)是 Epac 持续作用的重要下游蛋白。事实上,Western blot 发现,8-pCPT 处理可增强分离细胞中的 CaM 表达。此外,8-pCPT 诱导的、PKA 非依赖性的正性变力作用有利于通过 L 型钙通道增强细胞外 Ca 2+内流。然而,8-pCPT 也诱导了异常的 Ca 2+释放,如 Ca 2+波和额外的[Ca 2+](i)瞬变,提示有致心律失常作用。这些结果提供了关于 Epac 心脏作用的新见解,表明其在心脏肥大起始时心脏对病理刺激的初始代偿中起重要作用,有利于收缩,但也增加心律失常风险。